NO20033125L - Anvendelse av antigestagener til inhibering av fremskyndet endometriummodning under infertilitetsbehandling - Google Patents

Anvendelse av antigestagener til inhibering av fremskyndet endometriummodning under infertilitetsbehandling

Info

Publication number
NO20033125L
NO20033125L NO20033125A NO20033125A NO20033125L NO 20033125 L NO20033125 L NO 20033125L NO 20033125 A NO20033125 A NO 20033125A NO 20033125 A NO20033125 A NO 20033125A NO 20033125 L NO20033125 L NO 20033125L
Authority
NO
Norway
Prior art keywords
antigestagens
maturation during
endometrial maturation
infertility therapy
during infertility
Prior art date
Application number
NO20033125A
Other languages
English (en)
Other versions
NO20033125D0 (no
Inventor
Christa Hegele-Hartung
Holger Hess-Stumpp
Henning M Beier
Claudia Krusche
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/801,925 external-priority patent/US20020143000A1/en
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20033125D0 publication Critical patent/NO20033125D0/no
Publication of NO20033125L publication Critical patent/NO20033125L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
NO20033125A 2001-01-09 2003-07-08 Anvendelse av antigestagener til inhibering av fremskyndet endometriummodning under infertilitetsbehandling NO20033125L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75628601A 2001-01-09 2001-01-09
US09/801,925 US20020143000A1 (en) 2001-01-09 2001-03-09 Use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment
PCT/IB2002/001764 WO2002067910A2 (en) 2001-01-09 2002-01-09 The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment

Publications (2)

Publication Number Publication Date
NO20033125D0 NO20033125D0 (no) 2003-07-08
NO20033125L true NO20033125L (no) 2003-09-09

Family

ID=27116200

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033125A NO20033125L (no) 2001-01-09 2003-07-08 Anvendelse av antigestagener til inhibering av fremskyndet endometriummodning under infertilitetsbehandling

Country Status (25)

Country Link
US (1) US20040152684A1 (no)
EP (1) EP1365765B1 (no)
JP (1) JP2004520411A (no)
CN (1) CN1244329C (no)
AR (1) AR032390A1 (no)
AT (1) ATE367817T1 (no)
AU (1) AU2002253488B2 (no)
BG (1) BG107977A (no)
BR (1) BR0206367A (no)
CA (1) CA2433776A1 (no)
CZ (1) CZ20031864A3 (no)
DE (1) DE60221359T2 (no)
DK (1) DK1365765T3 (no)
EE (1) EE200300321A (no)
ES (1) ES2290284T3 (no)
HK (1) HK1065953A1 (no)
HR (1) HRP20030628A2 (no)
HU (1) HUP0302632A2 (no)
IL (1) IL156729A0 (no)
MX (1) MXPA03006156A (no)
NO (1) NO20033125L (no)
NZ (1) NZ526908A (no)
PL (1) PL361689A1 (no)
SK (1) SK8612003A3 (no)
WO (1) WO2002067910A2 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009034362A1 (de) * 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034367A1 (de) * 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de) * 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
US20130029953A1 (en) * 2011-07-28 2013-01-31 Klaus Nickisch Progesterone antagonists
ES2716862T3 (es) * 2014-12-22 2019-06-17 Ferring Bv Terapia con antagonistas del receptor de oxitocina en la fase lútea para la implantación y embarazo en mujeres que se someten a tecnologías de reproducción asistida
EP3214092A1 (en) 2016-03-04 2017-09-06 Bayer Pharma Aktiengesellschaft Prodrugs of the selective progesterone receptor modulator (sprm) (11.beta.,17.beta.)-17-hydroxy-11-[4-(methylsulphonyl)phenyl]-17-(pentafluoroethyl)estra-4,9-dien-3-one

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3533175A1 (de) * 1985-09-13 1987-03-19 Schering Ag Antigestagene zur verschiebung der endometrialen reifung
DE19706061A1 (de) * 1997-02-07 1998-08-13 Schering Ag Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
DE19860719A1 (de) * 1998-12-23 2000-06-29 Schering Ag Neue Testosteronderivate und ihre Verwendung zur Langzeittherapie von Androgen-abhängigen Erkrankungen

Also Published As

Publication number Publication date
HRP20030628A2 (en) 2005-06-30
JP2004520411A (ja) 2004-07-08
US20040152684A1 (en) 2004-08-05
BR0206367A (pt) 2003-12-23
CN1496263A (zh) 2004-05-12
BG107977A (bg) 2004-08-31
CA2433776A1 (en) 2002-09-06
IL156729A0 (en) 2004-02-08
DE60221359D1 (de) 2007-09-06
PL361689A1 (en) 2004-10-04
NO20033125D0 (no) 2003-07-08
EE200300321A (et) 2003-10-15
HUP0302632A2 (hu) 2003-11-28
ES2290284T3 (es) 2008-02-16
HK1065953A1 (en) 2005-03-11
AR032390A1 (es) 2003-11-05
DE60221359T2 (de) 2008-04-17
CN1244329C (zh) 2006-03-08
SK8612003A3 (en) 2004-03-02
WO2002067910A2 (en) 2002-09-06
CZ20031864A3 (en) 2004-03-17
DK1365765T3 (da) 2007-10-29
MXPA03006156A (es) 2003-09-16
WO2002067910A3 (en) 2003-02-06
AU2002253488B2 (en) 2007-02-15
NZ526908A (en) 2005-07-29
EP1365765A2 (en) 2003-12-03
EP1365765B1 (en) 2007-07-25
ATE367817T1 (de) 2007-08-15

Similar Documents

Publication Publication Date Title
HK1091840A1 (en) Methods and compositions for therapeutic use of rna interference
IL208892A0 (en) Use of hmg fragment as anti-inflammatory agents
HK1075619A1 (en) New uses for anti-malarial therapeutic agents
DE60212044D1 (de) Test der bukkalen Auflösung pharmazeutisch aktiver Stoffe
NO20030030D0 (no) Farmasöytiske blandinger av östrogene midler
AU2001294515A1 (en) Use of stat-6 inhibitors as therapeutic agents
HUP0201310A3 (en) Therapeutic use of selective pde10 inhibitors
DK1446012T3 (da) Bakteriolytisk kombinationsterapi til behandling af tumorer
NO20015112L (no) Anvendelse av glykosylceramidsynteseinhibitorer ved terapi
NO20026008L (no) Fremgangsmåte for behandling av cardiovaskul¶re sykdommer
NO20033125L (no) Anvendelse av antigestagener til inhibering av fremskyndet endometriummodning under infertilitetsbehandling
EE200200632A (et) Glükokortikoidravimeid sisaldavad preparaadid bronhopulmonaalsete haiguste raviks
EP1359885A4 (en) NOS-HEMMER FOR THE TREATMENT OF WRINKLES
ZA200306122B (en) The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment.
HK1060850A1 (en) Pharmaceutical composition for treatment of phimosis using topical corticosteroid
NO20023354D0 (no) Anvendelse av FSH til å behandle infertilitet
FR2832211B1 (fr) Isolation sous argon de cuve(s) de navire methanier
HUP0304003A2 (hu) Aromatáz inhibitor alkalmazása meddőség kezelésére alkalmas gyógyszerkészítmény előállítására
IL162509A0 (en) Use of deoxypeganine for treating clinical depression
IL160230A0 (en) Use of il-18 inhibitors
ITAN20020045A0 (it) Attrezzatura per pratica della terapia delle pietre calde
TW479522U (en) Structure of basin for soaking foot
TW567790U (en) Structure of placement closet for parking lot
GB0113987D0 (en) Use of terpenes as angiogenesis inhibitors
ITMI20011705A0 (it) Antiinfiammatori non asteroidei per il trattamento per via rettale dioligastenospermia

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application